Cambridge Healthtech’s 9th Annual

Feasibility and Site Selection

Leveraging Data, Technology, and Community Engagement

13-14 October 2026

Identifying the right sites is a critical, upstream decision that shapes trial timelines, enrollment success, and overall study execution. As regulations evolve and data availability varies across European health systems, traditional feasibility approaches are no longer sufficient. This track highlights how organisations are modernising feasibility and site selection using real-world data, predictive analytics, and improved data governance to better assess site capacity, patient availability, and the competitive landscape. Sessions will explore inclusive, regionally appropriate frameworks for identifying patient populations and aligning protocol requirements with real-world site capabilities. Attendees will gain practical insights into making smarter, data-informed site selection decisions that reduce uncertainty and set trials up for success from the start.

Coverage will include, but is not limited to:

Leveraging AI and predictive analytics in feasibility and site selection
Building and implementing a data-driven site selection approach 
Incorporating diversity considerations into feasibility assessment
Strategies to evaluate and reduce site burden and improve operations
Tools and strategies to improve site activation and study start-up

The deadline for priority consideration is 6 March 2026.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: